Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: J Clin Immunol. 2020 Jun 22;40(6):807–819. doi: 10.1007/s10875-020-00803-9

Table 1:

Clinical summary of the 45 Down Syndrome patients studied

Category Sub-category Number (n=45)
Sex (n, %) Male 29 (64.4%)
Female 16 (35.6%)

Age (years) Mean±SD 23.5±12.1
Range 3-53

Age groups (n, %) 3-10 7 (15.6%)
11-20 14 (31.1%)
21-30 12 (26.7%)
31-40 8 (17.8%)
Above 40 4 (8.9%)

Ethnicity (n, %) White or European 34 (75.6%)
Black or African American 10 (22.2%)
Asian 1 (2.2%)

Mucocutaneous infection or inflammation (n, %) Recurrent skin infection 12 (26.7%)
Otitis media 8 (17.8%)
Onychomycosis 7 (15.6%)
Candidiasis 3 (6.7%)
Pustules 3 (6.7%)
Tonsillitis 3 (6.7%)
Conjunctivitis 2 (4.4%)
Intertriginous dermatitis 1 (2.2%)

Other infection, unspecified (n, %) Varicella 16 (35.6%)
Pneumonia 4 (8.9%)
Systemic Candida infection 1 (2.2%)
Urinary tract infection 1 (2.2%)

Hypothyroidism (n, %) 7 (15.6%)

Cardiac abnormality (n, %) 7 (15.6%)

Positive ANA (n, %) 20 (44.4%)